Ignyta
Biotechnology, Health Care, Health Diagnostics
Founded in 2011-01-01
San Diego, California, United States
For Profit
About Ignyta
Ignyta is a scientifically-driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goal is to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide. Ignyta was incorporated in 2011 and operates in San Diego, California.
Company Metrics
- Employees: 101-250
- Monthly Visits: None
- Tech Stack: 19 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 375500000 USD
- Last Funding: 160000000 USD (Post-IPO Equity)
- Funding Status: M&A
Technology Stack
Ignyta actively uses 19 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Health Diagnostics
Headquarters: San Diego, California, United States